NCT01635855View on ClinicalTrials.gov

Belotero Post Approval Study

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Nasolabial Folds
Interventions
DEVICE

Belotero®

Hyaluronic acid dermal filler

Trial Locations (9)

90069

Los Angeles

Unknown

Birmingham

Los Angeles

San Francisco

New Haven

Metairie

Glenn Dale

Montclair

White Plains

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT01635855 - Belotero Post Approval Study | Biotech Hunter | Biotech Hunter